Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Jeanne Linke Northrop

Advertisement

Articles by Jeanne Linke Northrop

Dave Bearss, PhD, CEO, Halia Therapeutics Image courtesy of Halia Therapeutics

Pushing Boundaries to Revolutionize Chronic Inflammation Therapy

ByJeanne Linke Northrop
June 13th 2024

Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.

Advertisement

Latest Updated Articles

  • Dave Bearss, PhD, CEO, Halia Therapeutics Image courtesy of Halia Therapeutics
    Pushing Boundaries to Revolutionize Chronic Inflammation Therapy

    June 13th 2024



Advertisement
Advertisement

Trending on PharmExec

1

Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising, Alleging Misleading Dosing Comparisons

2

Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.

3

President Trump Announces Phased Generic Drug Tariff Plan: Report

4

Developing Better Drugs, Not Just More Drugs: Q&A with David Hung

5

FDA Grants Emergency Use Authorization for Seegene’s Multiplex PCR Assay

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us